In vivo characterization of cytokine profiles and viral load during murine cytomegalovirus-induced acute myocarditis

Cardiovascular Pathology

Volumn 19, Issue 2, 2010, Pages 83-93

  Ritter, Jethro Trees ^a   Tang Feldman, Yajarayma J ^a   Lochhead, G Raymond ^a   Estrada, Marko ^b   Lochhead, Stephanie ^a   Yu, Cindy ^c   Ashton Sager, Amanda ^c   Tuteja, Dipika ^a   Leutenegger, Christian ^b   Pomeroy, Claire ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Calcification; Cytokines; Inflammation; MCMV; Myocarditis; T cells

Indexed keywords

GAMMA INTERFERON; GREEN FLUORESCENT PROTEIN; INTERLEUKIN 10; INTERLEUKIN 6; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIFICATION; CD3+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; ENDOCARDIUM; EPICARDIUM; HEART MUSCLE; HEART RIGHT VENTRICLE; HISTOPATHOLOGY; IMMUNOREACTIVITY; IN VIVO STUDY; INFLAMMATION; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; VIRUS LOAD; VIRUS MYOCARDITIS;

ACUTE DISEASE; ANIMALS; APOPTOSIS; CALCINOSIS; CYTOKINES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MICE; MICE, INBRED BALB C; MICRODISSECTION; MYOCARDITIS; MYOCARDIUM; MYOCYTES, CARDIAC; RNA, MESSENGER; VIRAL LOAD;

EID: 75149155282     PISSN: 10548807     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carpath.2008.12.001     Document Type: Article

References (29)

1. See D.M., and Tilles J.G. Viral myocarditis. Rev Infect Dis 13 (1991) 951-956
2. Kearney M.T., Cotton J.M., Richardson P.J., and Shah A.M. Viral myocarditis and dilated cardiomyopathy: mechanisms, manifestations, and management. Postgrad Med J 77 (2001) 4-10
3. McManus B.M., Chow L.H., Wilson J.E., Anderson D.R., Gulizia J.M., Gauntt C.J., Klingel K.E., Beisel K.W., and Kandolf R. Direct myocardial injury by enterovirus: a central role in the evolution of murine myocarditis. Clin Immunol Immunopathol 68 (1993) 159-169
4. Lenzo C.L., Fairweather D., Shellam G.R., and Lawson C.M. Immunomodulation of murine cytomegalovirus-induced myocarditis in mice treated with lipopolysaccharide and tumor necrosis factor. Immunology 213 (2001) 52-61
5. Lenzo C.L., Fairweather D., Cull V., Shellam G.R., and James (Lawson) C.M. Characterization of murine cytomegalovirus myocarditis: cellular infiltration of the heart and viral persistence. Mol Cell Cardiol 34 (2002) 629-640
6. Lenzo C.L., Mansfield J.P., Sivamoorthy S., Cull V.S., and James C.M. Cytokine expression in murine cytomegalovirus-induced myocarditis: modulation with interferon-α therapy. Cell Immunol 223 (2003) 77-86
7. Lawson C.M., O'Donoghue H.L., and Reed W.D. Mouse cytomegalovirus infection induces antibodies which cross-react with the virus and cardiac myosin: a model for the study of molecular mimicry in the pathogenesis of viral myocarditis. Immunol 75 (1992) 513-519
8. Wada H., Saito K., Kanda T., Kobayashi I., Fujii H., Fujigaki S., et al. Tumor necrosis factor-α (TNF-α) plays a protective role in acute viral myocarditis in mice- a study using mice lacking TNF-α receptor. Circulation 103 (2001) 743-749
9. Cull V.S., Barlett E.J., and James C.M. Type I interferon gene therapy protects against cytomegalovirus induced myocarditis. Immunology 106 (2002) 428-437
10. Pomeroy C., Hilleren P.J., and Jordan M.C. Latent murine cytomegalovirus DNA in splenic stromal cells of mice. J Virol 65 (1991) 3330-3334
11. Tang-Feldman Y.J., Wojtowicz A., Lochhead G.R., Hale M.A., Li Y., and Pomeroy C. Use of quantitative real-time PCR (qRT-PCR) to measure cytokine transcription and viral load in murine cytomegalovirus infection. J Virol Methods 131 (2006) 122-129
12. Henry S.C., Schmader K., Brown T.T., Miller S.E., Howell D.N., Daley G.G., and Hamilton J.D. Enhanced green fluorescent protein as a marker for localizing murine cytomegalovirus in acute and latent infection. J Virol Methods 89 (2000) 61-73
13. Kipar A., Leutenegger C.M., Hetzel U., Akens M.K., Mislin C.N., Reinacher M., and Lutz H. Cytokine mRNA levels in isolated feline monocytes. Vet Immunol Immunopathol 78 (2001) 305-315
14. SAS Institute, Inc. SAS® Version 9.1 (2002-2003), SAS Institute, Inc, Cary (NC)
15. Kawai C. From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death-learning from the past for the future. Circulation 99 (1999) 1091-1100
16. Matsumori A., Yamada T., Suzuki H., Matoba Y., and Sasayama S. Increased circulating cytokines in patients with myocarditis and cardiomyopathy. Br Heart J 72 (1994) 561-566
17. Mason J. Myocarditis and dilated cardiomyopathy: an inflammatory link. Cardiovasc Res 60 (2003) 5-10
18. Goldfeld A.E., and Maniatis T. Coordinate viral induction of tumor necrosis factor and interferon in human B cells and monocytes. Proc Natl Acad Sci U S A 86 (1989) 1490-1494
19. Yamada T., Matsumori A., and Sasayama S. Therapeutic effect of anti-tumor necrosis factor-alpha antibody on the murine model of viral myocarditis induced by encephalomyocarditis virus. Circulation 89 (1994) 846-851
20. Matsumori A., Tomioka N., and Kawai C. Protective effect of recombinant alpha-interferon on coxsackievirus B3 myocarditis in mice. Heart J 115 (1988) 1229-1232
21. Lane J.R., Neumann D.A., Lafond-Walker A., Herskowitz A., and Rose N.R. Interleukin 1 or tumor necrosis factor can promote Coxsackie B3-induced myocarditis in resistant B10 A mice. J Exp Med 175 (1992) 1123-1129
22. Saraste A., Arola A., Vuorinen T., Kyto V., et al. Cardiomyocyte apoptosis in experimental coxsakievirus B3 myocarditis. Cardiovasc Pathol 12 (2003) 255-262
23. Leung W.C.T., Hata J., and Hashimoto K. Murine cytomegalovirus infection model in BALB/c mice-2. Pericarditis with myocardial involvement. Tokai J Exp Clin Med 11 (1986) 303-311
24. Gang D.L., Barrett L.V., Wilson E.J., Rubin R.H., and Medearis D.N. Myopericarditis and enhanced dystrophic cardiac calcification in murine cytomegalovirus infection. Am J Pathol 124 (1986) 207-215
25. Oka K., Oohira K., Yatabe Y., Tanaka T., Kurano K., et al. Fulminant myocardits demonstrating uncommon morphology- a report of two autopsy cases. Virchows Arch 446 (2005) 259-264
26. Funseth E., Lindh U., Wesslen L., Friman G., and Ilback N.G. Trace element changes in the myocardium during coxsackievirus B3 myocarditis in the mouse. Biol Trace Elem Res 76 (2000) 149-160
27. Sole M.J., and Liu P. Viral myocarditis: a paradigm for understanding the pathogenesis and treatment of dilated myocarditis. J Am Coll Cardiol 22 Suppl A (1993) 99A-105A
28. Huber S.A., and Lodge P.A. Coxsackievirus B-3 myocarditis in Balb/c mice: evidence for autoimmunity to myocyte antigens. Am J Pathol 116 (1984) 21-29
29. Kishomoto C., Kuribayashi K., Masuda T., Tomioka N., and Hawai C. Immunological behavior of lymphocytes in experimental viral myocarditis: significance of T-lymphocytes in the severity of myocarditis and silent myocarditis in BALB/c un/un mice. Circulation 71 (1985) 1247-1254